产品详情 |
Edit |   |
Product Name | MLN-9708 |
Description | MLN-9708 is a prodrug of Ixazomib citrate (MLN-2238). MLN-9708 is an orally bioavailable next-generation proteasome inhibitor (PI) with potential potent anticancer activity in both hematologic and solid tumor xenograft models with better pharmacokinetic and pharmacodynamic features than PS-341 (Cat. No. 1846). MW: 517.12. Purity ≥98% by HPLC |
Size | 5 mg |
Concentration | n/a |
Applications | n/a |
Other Names | 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid; ixazomib |
Gene, Accession, CAS # | CAS: 1239908-20-3 |
Catalog # | B2195-5 |
Price | |
Order / More Info | MLN-9708 from BIOVISION, INC. |
Product Specific References | n/a |
产品资料 |
|
|